DuPont de Nemours Past Earnings Performance
Past criteria checks 1/6
DuPont de Nemours has been growing earnings at an average annual rate of 43.8%, while the Chemicals industry saw earnings declining at 3.8% annually. Revenues have been declining at an average rate of 9.2% per year. DuPont de Nemours's return on equity is 2.2%, and it has net margins of 4.2%.
Key information
43.8%
Earnings growth rate
42.7%
EPS growth rate
| Chemicals Industry Growth | 4.3% |
| Revenue growth rate | -9.2% |
| Return on equity | 2.2% |
| Net Margin | 4.2% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How DuPont de Nemours makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 12,192 | 508 | 1,527 | 521 |
| 30 Jun 24 | 12,058 | 318 | 1,507 | 515 |
| 31 Mar 24 | 11,981 | 404 | 1,452 | 506 |
| 31 Dec 23 | 12,068 | 494 | 1,417 | 508 |
| 30 Sep 23 | 12,274 | 895 | 1,394 | 503 |
| 30 Jun 23 | 12,533 | 963 | 1,380 | 504 |
| 31 Mar 23 | 12,761 | 1,065 | 1,399 | 520 |
| 31 Dec 22 | 13,017 | 1,012 | 1,439 | 536 |
| 30 Sep 22 | 13,159 | 1,064 | 1,481 | 561 |
| 30 Jun 22 | 13,041 | 960 | 1,556 | 569 |
| 31 Mar 22 | 12,823 | 989 | 1,565 | 561 |
| 31 Dec 21 | 12,566 | 1,159 | 1,572 | 557 |
| 30 Sep 21 | 13,070 | 1,453 | 1,596 | 568 |
| 30 Jun 21 | 13,500 | 1,286 | 1,571 | 571 |
| 31 Mar 21 | 13,685 | -1,496 | 1,589 | 591 |
| 31 Dec 20 | 11,128 | -1,377 | 1,480 | 565 |
| 30 Sep 20 | 15,792 | -2,694 | 1,912 | 697 |
| 30 Jun 20 | 17,589 | -2,406 | 2,137 | 782 |
| 31 Mar 20 | 19,768 | -1,147 | 2,355 | 861 |
| 31 Dec 19 | 15,436 | -227 | 1,985 | 689 |
| 30 Sep 19 | 21,765 | -620 | 2,663 | 986 |
| 30 Jun 19 | 22,022 | -896 | 2,746 | 1,025 |
| 31 Mar 19 | 22,411 | 230 | 2,862 | 1,063 |
| 31 Dec 18 | 22,594 | 233 | 2,932 | 1,070 |
| 30 Sep 18 | 37,203 | -1,249 | 4,387 | 1,594 |
| 30 Jun 18 | 46,874 | -809 | 4,647 | 1,858 |
| 31 Mar 18 | 54,851 | 517 | 4,626 | 1,996 |
| 31 Dec 17 | 11,672 | 88 | 1,580 | 657 |
| 30 Sep 17 | 55,438 | 2,698 | 3,257 | 1,780 |
| 30 Jun 17 | 52,567 | 2,882 | 3,019 | 1,651 |
| 31 Mar 17 | 50,685 | 4,672 | 3,014 | 1,642 |
| 31 Dec 16 | 48,158 | 3,956 | 2,919 | 1,593 |
| 30 Sep 16 | 46,600 | 7,490 | 2,865 | 1,563 |
| 30 Jun 16 | 46,153 | 8,056 | 2,815 | 1,546 |
| 31 Mar 16 | 47,111 | 6,079 | 2,868 | 1,576 |
| 31 Dec 15 | 48,778 | 7,294 | 2,948 | 1,598 |
| 30 Sep 15 | 51,700 | 4,520 | 3,021 | 1,622 |
| 30 Jun 15 | 54,069 | 4,084 | 3,095 | 1,649 |
| 31 Mar 15 | 56,076 | 3,832 | 3,079 | 1,639 |
| 31 Dec 14 | 58,167 | 3,405 | 3,106 | 1,647 |
| 30 Sep 14 | 58,169 | 3,632 | 3,120 | 1,694 |
| 30 Jun 14 | 57,498 | 3,376 | 3,065 | 1,703 |
| 31 Mar 14 | 57,158 | 4,820 | 3,030 | 1,701 |
| 31 Dec 13 | 57,080 | 4,409 | 3,022 | 1,745 |
Quality Earnings: 0A6B has a large one-off loss of $1.1B impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 0A6B's current net profit margins (4.2%) are lower than last year (7.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 0A6B has become profitable over the past 5 years, growing earnings by 43.8% per year.
Accelerating Growth: 0A6B's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 0A6B had negative earnings growth (-43.2%) over the past year, making it difficult to compare to the Chemicals industry average (-36.8%).
Return on Equity
High ROE: 0A6B's Return on Equity (2.2%) is considered low.